The platform will be used to diagnose and treat cancers, including lung and brain tumours
Category: Oncology
The CVLP platform will speed up access to BioNTech and Genentech’s mRNA personalised cancer vaccines
JHU083 reduced tumour growth and triggered tumour cell death in mice
The findings could potentially lead to new therapies and could stop the growth of cancers
The paper identifies the roles and differences between LARP4A and LARP4B in sarcoma and carcinoma cancers
Both will develop cancer vaccine candidates in selected haematological and solid tumour indications
Despite tremendous advances in breast cancer research and treatment over the past three decades many groups are systematically […]
NSCLC is the most common type of lung cancer and is responsible for up to 85% of all […]
Prostate cancer is responsible for around 12,000 deaths a year in the UK and is the second biggest […]
Solid tumour cancers account for 90% of adult human cancers and 50% of childhood malignancies